Clinical Trial Update: Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya [NA]

View source ↗

Summary

Clinical trial in Kenya completed evaluation of discontinuing trimethoprim-sulfamethoxazole prophylaxis in adults on antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Trimethoprim-sulfamethoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: University of Washington | Conditions: HIV Infections, Acquired Immunodeficiency Syndrome | NA | Status: COMPLETED